Back to Screener

Healthcare

Lexicon Pharmaceuticals, Inc.(LXRX)

Live Price

Offline

$2.29

+3.15% today

1Y Change

+123.33%

Window

Jun 25, 2025 โ†’ Jun 18, 2026

Market Cap
$690.00M
Revenue Growth
+60.2%
EPS Growth
+77.8%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 25, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Lexicon Pharmaceuticals, Inc. (LXRX) is a Healthcare stock with a market cap of $690.00M and listed on NASDAQ. The stock last traded around $2.29 and up 123.3% across the available one-year price window (Jun 25, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +60.2%, EPS growth of +77.8%, a dividend yield of 0.0%. What stands out right now is revenue +60.2%, EPS +77.8%, free cash flow +62.3% with operating margin -98.2% and ROIC -28.7%. Valuation already assumes a fairly strong business story at price/sales 13.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines LXRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LXRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LXRX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

LXRX Max Drawdown

-34.09%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LXRX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.04
โ€”
โ€”
Est 9789.7B
โ€”
May 12
โ€”
Mar 5, 26
โœ“
-0.04
Est -0.07
+42.9%
5493.0B
Est 3141.6B
+74.8%
Mar 5
โ€”
Nov 6, 25
โœ“
-0.04
Est -0.07
+42.9%
14182.0B
Est 3141.6B
+351.4%
Nov 6
โ€”
Aug 6, 25
โœ“
0.01
Est -0.08
+112.5%
28866.0B
Est 5811.5B
+396.7%
Aug 6
โ€”
May 13, 25
โœ“
-0.07
Est -0.10
+30.0%
1262.0B
Est 1306.7B
-3.4%
May 13
โ€”
Mar 6, 25
โœ“
-0.09
Est -0.11
+18.2%
26554.0B
Est 2817.0B
+842.6%
Mar 6
โ€”
Nov 12, 24
โœ—
-0.18
Est -0.17
-5.9%
1750.0B
Est 6479.4B
-73.0%
Nov 12
โ€”
Aug 1, 24
โœ“
-0.17
Est -0.18
+5.6%
1647.0B
Est 8160.0B
-79.8%
Aug 1
โ€”
May 2, 24
โœ—
-0.20
Est -0.18
-11.1%
1130.0B
Est 1400.0B
-19.3%
May 2
โ€”
Mar 11, 24
โœ“
-0.20
Est -0.23
+13.0%
702.0B
Est 1240.0B
-43.4%
Mar 11
โ€”
Nov 8, 23
โœ“
-0.21
Est -0.22
+4.5%
162.0B
Est 4790.0B
-96.6%
Nov 8
โ€”
Aug 3, 23
โœ—
-0.22
Est -0.17
-29.4%
317.0B
Est 4060.0B
-92.2%
Aug 3
โ€”
May 2, 23
โ€”
-0.17
Est -0.17
0.0%
24.0B
Est 30.0B
-20.0%
May 2
โ€”
Mar 2, 23
โœ—
-0.16
Est -0.14
-14.3%
28.0B
Est 50.0B
-44.0%
Mar 2
โ€”
Nov 9, 22
โœ“
-0.13
Est -0.15
+13.3%
39.0B
Est 50.0B
-22.0%
Nov 9
โ€”
Aug 2, 22
โœ—
-0.16
Est -0.15
-6.7%
35.0B
Est 100.0B
-65.0%
Aug 2
โ€”
May 5, 22
โ€”
-0.16
Est -0.16
0.0%
37.0B
Est 50.0B
-26.0%
May 5
โ€”
Feb 28, 22
โ€”
-0.17
Est -0.17
0.0%
14.0B
Est 14.8B
-5.3%
Feb 28
โ€”
Nov 3, 21
โœ“
-0.16
Est -0.18
+11.1%
23.0B
Est 120.0B
-80.8%
Nov 3
โ€”
Jul 30, 21
โœ“
-0.13
Est -0.16
+18.8%
234.0B
Est 10.0B
+2240.0%
Jul 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener